Ledger.Open graph →
SEC Form D · filed July 7, 2020

Iterum Therapeutics plc

Offering
$2.8M
Sold
$2.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
DUBLIN, Ireland
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Brenton K. Ahrens · Dublin, IrelandDirectorShahzad M. Malik · Dublin, IrelandDirectorMichael M. Dunne · Dublin, IrelandExecPatrick J. Heron · Dublin, IrelandDirectorJudith M. Matthews · Dublin, IrelandExecDavid M. Kelly · Dublin, IrelandDirectorRonald M. Hunt · Dublin, IrelandDirectorLouise M. Barrett · Dublin, IrelandExecCorey N. Fishman · Dublin, IrelandExec · DirectorMark K. Chin · Dublin, IrelandDirectorJacquilyn A. Dmytrenko · Union Springs, NYDirectorSa Zhou · Beijing, IsraelExecEllen M. May · Union Springs, NYDirectorKelly R. Wade · Union Springs, NYDirectorThea R. Miller · Union Springs, NYDirectorStephen L. Zabriskie · Union Springs, NYExec · DirectorScott L. Babcock · Union Springs, NYDirectorNeil Schimmel · Woodland Hills, CAExecMary L. May · Union Springs, NYDirectorDonald L. Taylor · Union Springs, NYExecMichael Hepworth · Raleigh, NCDirectorMark Zorko · Raleigh, NCDirectorPeter Dielwart · Raleigh, NCDirectorKalaimani Ponnusamy · FRISCO, TXDirectorMurali Radhakrishnan · FRISCO, TXDirectorKStone Partners LLC · Harrison, NYDirectorPriscilla K. Balgobin-Bhoyrul · GRAND CAYMAN, Cayman IslandsExec · DirectorAshwin K. Foogooa · GRAND CAYMAN, Cayman IslandsExecSooriehnanda K. Ramanjooloo · GRAND CAYMAN, Cayman IslandsExecMaureen Ocampo · LOS ANGELES, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗